Cachet Pharmaceutical Co., Ltd. (002462.SZ)
CNY 13.73
(-0.94%)
CNY 13.73
(-0.94%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.97 Billion CNY | -6.16% |
| 2022 | 2.1 Billion CNY | -1.55% |
| 2021 | 2.14 Billion CNY | 0.31% |
| 2020 | 2.13 Billion CNY | -6.0% |
| 2019 | 2.27 Billion CNY | 23.55% |
| 2018 | 1.83 Billion CNY | 33.09% |
| 2017 | 1.38 Billion CNY | 15.33% |
| 2016 | 1.19 Billion CNY | 13.68% |
| 2015 | 1.05 Billion CNY | 46.69% |
| 2014 | 717.94 Million CNY | 112.8% |
| 2013 | 337.38 Million CNY | 51.94% |
| 2012 | 222.05 Million CNY | 30.06% |
| 2011 | 170.73 Million CNY | 0.34% |
| 2010 | 170.16 Million CNY | 11.29% |
| 2009 | 152.9 Million CNY | 12.56% |
| 2008 | 135.83 Million CNY | 26.72% |
| 2007 | 107.18 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 419.73 Million CNY | -8.82% |
| 2024 Q3 | 382.4 Million CNY | 6.0% |
| 2024 Q2 | 360.74 Million CNY | -14.05% |
| 2023 Q3 | 492.39 Million CNY | -11.28% |
| 2023 Q4 | 460.33 Million CNY | -6.51% |
| 2023 Q1 | 469.98 Million CNY | -21.14% |
| 2023 FY | 1.97 Billion CNY | -6.16% |
| 2023 Q2 | 554.99 Million CNY | 18.09% |
| 2022 FY | 2.1 Billion CNY | -1.55% |
| 2022 Q1 | 510.53 Million CNY | -4.68% |
| 2022 Q4 | 595.93 Million CNY | 20.18% |
| 2022 Q3 | 495.85 Million CNY | -1.85% |
| 2022 Q2 | 505.21 Million CNY | -1.04% |
| 2021 Q3 | 562.13 Million CNY | 4.52% |
| 2021 FY | 2.14 Billion CNY | 0.31% |
| 2021 Q2 | 537.8 Million CNY | 6.44% |
| 2021 Q1 | 505.24 Million CNY | -15.41% |
| 2021 Q4 | 535.57 Million CNY | -4.72% |
| 2020 Q2 | 512.54 Million CNY | 38.7% |
| 2020 Q4 | 597.3 Million CNY | -8.78% |
| 2020 FY | 2.13 Billion CNY | -6.0% |
| 2020 Q1 | 369.54 Million CNY | -42.76% |
| 2020 Q3 | 654.76 Million CNY | 27.75% |
| 2019 FY | 2.27 Billion CNY | 23.55% |
| 2019 Q3 | 562.14 Million CNY | 0.53% |
| 2019 Q1 | 503.43 Million CNY | -5.08% |
| 2019 Q4 | 645.57 Million CNY | 14.84% |
| 2019 Q2 | 559.19 Million CNY | 11.08% |
| 2018 FY | 1.83 Billion CNY | 33.09% |
| 2018 Q3 | 460.96 Million CNY | 1.39% |
| 2018 Q1 | 391.6 Million CNY | -6.35% |
| 2018 Q2 | 454.66 Million CNY | 16.1% |
| 2018 Q4 | 530.36 Million CNY | 15.06% |
| 2017 Q4 | 418.15 Million CNY | 37.98% |
| 2017 Q2 | 335.88 Million CNY | 3.8% |
| 2017 FY | 1.38 Billion CNY | 15.33% |
| 2017 Q1 | 323.59 Million CNY | -2.89% |
| 2017 Q3 | 303.05 Million CNY | -9.77% |
| 2016 FY | 1.19 Billion CNY | 13.68% |
| 2016 Q4 | 333.23 Million CNY | 21.52% |
| 2016 Q1 | 290.61 Million CNY | -6.76% |
| 2016 Q2 | 299.12 Million CNY | 2.93% |
| 2016 Q3 | 274.21 Million CNY | -8.33% |
| 2015 Q3 | 252.78 Million CNY | -2.44% |
| 2015 Q1 | 229.56 Million CNY | -14.13% |
| 2015 Q2 | 259.09 Million CNY | 12.86% |
| 2015 FY | 1.05 Billion CNY | 46.69% |
| 2015 Q4 | 311.7 Million CNY | 23.31% |
| 2014 Q2 | 153.17 Million CNY | 35.17% |
| 2014 FY | 717.94 Million CNY | 112.8% |
| 2014 Q4 | 267.32 Million CNY | 45.19% |
| 2014 Q3 | 184.12 Million CNY | 20.21% |
| 2014 Q1 | 113.31 Million CNY | -6.94% |
| 2013 Q2 | 76.1 Million CNY | 17.72% |
| 2013 Q3 | 74.86 Million CNY | -1.64% |
| 2013 Q1 | 64.64 Million CNY | -2.51% |
| 2013 Q4 | 121.76 Million CNY | 62.65% |
| 2013 FY | 337.38 Million CNY | 51.94% |
| 2012 Q4 | 66.31 Million CNY | 31.03% |
| 2012 FY | 222.05 Million CNY | 30.06% |
| 2012 Q2 | 57.42 Million CNY | 20.36% |
| 2012 Q3 | 50.6 Million CNY | -11.87% |
| 2012 Q1 | 47.71 Million CNY | -1.43% |
| 2011 Q3 | 39.71 Million CNY | -14.96% |
| 2011 Q1 | 35.92 Million CNY | -23.48% |
| 2011 Q2 | 46.69 Million CNY | 30.0% |
| 2011 Q4 | 48.4 Million CNY | 21.89% |
| 2011 FY | 170.73 Million CNY | 0.34% |
| 2010 Q2 | 44.95 Million CNY | 23.5% |
| 2010 Q4 | 46.94 Million CNY | 12.13% |
| 2010 Q3 | 41.86 Million CNY | -6.88% |
| 2010 FY | 170.16 Million CNY | 11.29% |
| 2010 Q1 | 36.4 Million CNY | -11.89% |
| 2009 Q3 | 39.82 Million CNY | 0.0% |
| 2009 Q4 | 41.31 Million CNY | 3.74% |
| 2009 FY | 152.9 Million CNY | 12.56% |
| 2008 FY | 135.83 Million CNY | 26.72% |
| 2007 FY | 107.18 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Yixintang Pharmaceutical Group Co., Ltd. | 5.55 Billion CNY | 64.372% |
| ZJAMP Group Co., Ltd. | 2.51 Billion CNY | 21.464% |
| Luyan Pharma Co.,Ltd. | 1.5 Billion CNY | -31.28% |
| Ji Yao Holding Group Co., Ltd. | 81.67 Million CNY | -2321.31% |